Last 64.25 INR
Change Today 0.00 / 0.00%
Volume 0.0
BLIS On Other Exchanges
Symbol
Exchange
BLIS is not on other exchanges.
As of 6:05 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

bliss gvs pharma ltd (BLIS) Snapshot

Open
65.80
Previous Close
64.25
Day High
66.40
Day Low
63.50
52 Week High
09/9/14 - 76.70
52 Week Low
05/28/14 - 38.95
Market Cap
6.6B
Average Volume 10 Days
48.7K
EPS TTM
3.97
Shares Outstanding
103.1M
EX-Date
08/13/14
P/E TM
16.2x
Dividend
0.50
Dividend Yield
0.78%
Current Stock Chart for BLISS GVS PHARMA LTD (BLIS)

Related News

No related news articles were found.

bliss gvs pharma ltd (BLIS) Related Businessweek News

No Related Businessweek News Found

bliss gvs pharma ltd (BLIS) Details

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India and internationally. The company offers therapeutic products, such as anti-fungal, laxative, anti-haemorrhoidal, anti-spasmodic, anti-malarial, anti-biotic, anti-microbial, anthelmintic, anti-diarrhoeal, anti-inflammatory, anti-pyretic, analgesic, anti-diabetic, anti-hypertensive, anti-emetic, anti-depressant, erectile dysfunction, multivitamin, anti-allergic, and antacid. It also provides over-the counter products, including herbal lozenges, shampoos, medicated dusting powders, herbal roll on products, and medicated and moisturizing soaps. In addition, the company provides female contraceptive under the Today brand name; and contract manufacturing services, as well as trades in pharmaceuticals. The company offers its products in various dosage forms, such as suppositories; pessaries; tablets; capsules; suspensions; syrups; dry powder injectables; injectables in ampoules; eye/ear/nasal drops; soft gelatin capsules; creams, gels, and ointments; and transdermal patches. The company was incorporated in 1984 and is based in Mumbai, India.

Founded in 1984

bliss gvs pharma ltd (BLIS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

bliss gvs pharma ltd (BLIS) Key Developments

Bliss Eyes Majority Stake In Shree Sales

Bliss Gvs Pharma Limited (BSE:506197) intends to acquire a majority stake in Shree Sales Corporation Pvt. Ltd. The Board of Directors at its meeting on October 30, 2014 has approved to consider, negotiate and finalize the acquisition of substantial stake in Shree Sales.

Bliss Gvs Pharma Limited Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Bliss Gvs Pharma Limited reported unaudited standalone earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported net sales/income from operations of INR 875.57 million compared to INR 971.86 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 277.57 million compared to profit from operations before other income, finance cost and exceptional items of INR 271.79 million a year ago. Profit from ordinary activities before tax was INR 323.79 million compared to profit from ordinary activities before tax of INR 343.00 million a year ago. Net profit for the period was INR 215.67 million or INR 2.09 per diluted share compared to net profit for the period of INR 235.33 million or INR 2.28 per diluted share a year ago. For the six months, the company reported net sales/income from operations of INR 1,573.66 million compared to INR 1,709.04 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 480.78 million compared to profit from operations before other income, finance cost and exceptional items of INR 393.40 million a year ago. Profit from ordinary activities before tax was INR 529.60 million compared to profit from ordinary activities before tax of INR 607.50 million a year ago. Net profit for the period was INR 355.62 million or INR 3.45 per diluted share compared to net profit for the period of INR 417.84 million or INR 4.05 per diluted share a year ago.

Bliss Gvs Pharma Limited, Board Meeting, Oct 30, 2014

Bliss Gvs Pharma Limited, Board Meeting, Oct 30, 2014. Agenda: To consider enlargement of the object of the company by inclusion of commodities trading; to consider, negotiate & finalize purchase of substantial stake in Shree Sales Pack Pvt Ltd, who presently carries majorities of packaging business for the company; and to consider the proposal of opening office of the company at London either by setting a subsidiary or representative office.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BLIS:IN 64.25 INR 0.00

BLIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BLIS.
View Industry Companies
 

Industry Analysis

BLIS

Industry Average

Valuation BLIS Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BLISS GVS PHARMA LTD, please visit www.blissgvspharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.